Financial incentives for hospitals boost rapid changes to opioid use disorder treatment
Offering financial incentives to hospitals shows strong potential to drive swift system and practice changes to intervene in the opioid epidemic, Penn Medicine research finds
2021-03-01
(Press-News.org) PHILADELPHIA-- Hospital emergency departments (EDs) not only care for patients with overdose and other complications from opioid use, but they also serve as vital touch points to engage patients into longer-term treatment. After an overdose, patients are at risk for repeat overdose and death. Pennsylvania is unique in establishing a voluntary incentive program to improve the rate at which patients with opioid use disorder receive follow-up treatment after emergency department care. Evaluations of the program show that financial incentives are effective in producing rapid treatment innovations for opioid use disorder.
In a study, researchers at the Perelman School of Medicine at the University of Pennsylvania found that Pennsylvania's financial incentive policy encouraged hospitals to enact rapid system and practice changes to support treatment for opioid use disorder for patients visiting the ED. The study, which was recently published in Psychiatric Services, evaluates the efficacy of the Opioid Hospital Quality Improvement Program (O-HQIP), which Pennsylvania pioneered in 2019. The program seeks to increase the rate of follow-up treatment for Medicaid patients within seven days of an ED encounter for opioid-related illness by offering financial compensation to hospitals who participated in the program.
"Policy makers have recognized that strengthening the linkage from the ED to treatment is an opportunity to combat the opioid epidemic," said senior author Zachary Meisel, MD, MPH, MSHP, an associate professor of Emergency Medicine and director of the Center for Emergency Care Policy and Research at Penn. "Offering financial incentives provides momentum for efforts to improve treatment access for opioid use disorder."
The program identified four distinct treatment pathways: initiation of buprenorphine treatment during the ED encounter; warm handoff to outpatient treatment; referral to treatment for pregnant patients; and inpatient initiation of methadone or buprenorphine treatment. An initial incentive for participation was paid to hospitals in 2019 and was contingent on participation in all four pathways, with lesser payments for partial participation. In future years, hospital can earn additional incentives for improvements in performance.
To evaluate the degree of the program's success, researchers conducted 20 semistructured interviews with leaders from a diverse sample of hospitals and health systems across Pennsylvania. Study interviews revealed that the incentives oriented institutional priorities toward expanding opioid treatment access. Hospitals were often on the cusp of change and responded to this nudge to prioritize opioid treatment access. However, the study also revealed that most hospitals--specifically, smaller or independent hospitals with lower volumes of patients with opioid use disorder--were unable to justify investing in these resources internally. Some hospitals noted resources as a barrier to participation, despite the incentive payments.
Finally, while initiating buprenorphine in the ED is proven to improve patients' health outcomes and retention in treatment, many hospitals found implementing a pathway for buprenorphine difficult and time-consuming, and all partially participating hospitals chose to forgo this pathway.
"Future work is needed to determine the effectiveness in improving patient outcomes not only for the this initiative in Pennsylvania, but also for emerging treatment methods and payment innovations in the care of patients with opioid use disorder," said Jeanmarie Perrone, MD, Director of the Division of Medical Toxicology and Addiction Medicine Initiatives, and a professor of Emergency Medicine at Penn. "Specifically, given that evidence supports improved treatment retention after ED initiation of buprenorphine rather than referral for initiation, incentives are needed that overcome the multifaceted barriers for this key treatment modality."
INFORMATION:
This project was supported by pilot grant from the National Institute of Mental Health (P50 MH-113840) to the Pennsylvania ALACRITY Center.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center--which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report--Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation's first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.
ELSE PRESS RELEASES FROM THIS DATE:
2021-03-01
Oak Brook, IL - The March edition of SLAS Discovery features the cover article, "Therapeutic and Vaccine Options for COVID-19: Status After 6 Months of the Disease Outbreak" by Christian Ogaugwu (Federal University Oye-Ekiti, Ekiti State, Nigeria ), Dawid Maciorowski, Subba Rao Durvasula, Ph.D., Ravi Durvasula, M.D., and Adinarayana Kunamneni, Ph.D. (Loyola University Medical Center, Maywood, IL, USA).
This cover article focuses on the therapeutic and vaccine options available against the novel coronavirus, roughly six months after the outbreak; because the COVID-19-related death toll worldwide had reached 500,000 in six months (and ballooned to over 2,000,000 at the time of publishing) the importance of options to temper the disease cannot be overemphasized. The article ...
2021-03-01
Major changes in bereavement care have occurred during the COVID-19 pandemic, amid a flood of demand for help from bereaved people, according to new research from the University of Cambridge. The first major study of pandemic-related changes in bereavement care has found that the switch to remote working has helped some services to reach out, but many practitioners feel they do not have capacity to meet people's needs.
It is estimated that for every death, nine people are affected by bereavement. The scale of the impact of the COVID-19 pandemic on those ...
2021-02-28
MINNEAPOLIS - Obstructive sleep apnea is when breathing is repeatedly interrupted during sleep. Research has shown people with this sleep disorder have an increased risk of developing cognitive impairment and Alzheimer's disease. Yet, it is treatable. A preliminary study released today, February 28, 2021, has found that obstructive sleep apnea is common in people with cognitive impairment. The study will be presented at the American Academy of Neurology's 73rd Annual Meeting being held virtually April 17 to 22, 2021.
Cognitive impairment includes memory and thinking problems that affect ...
2021-02-28
Red supergiants are a class of star that end their lives in supernova explosions. Their lifecycles are not fully understood, partly due to difficulties in measuring their temperatures. For the first time, astronomers develop an accurate method to determine the surface temperatures of red supergiants.
Stars come in a wide range of sizes, masses and compositions. Our sun is considered a relatively small specimen, especially when compared to something like Betelgeuse which is known as a red supergiant. Red supergiants are stars over nine times the mass of our sun, and all this mass means that when they die they do so with extreme ferocity in an enormous explosion known as a supernova, in particular what is known as a Type-II supernova.
Type II supernovae seed the cosmos with elements ...
2021-02-27
Tokyo, Japan - Researchers from Tokyo Metropolitan University have revealed how liquid foams collapse by observing individual collapse "events" with high-speed video microscopy. They found that cracks in films led to a receding liquid front which sweeps up the original film border, inverts its shape, and releases a droplet which hits and breaks other films. Their observations and physical model provide key insights into how to make foams more or less resistant to collapse.
Understanding how foams collapse is serious business. Whether it's ensuring fire extinguishing foams stay long enough to put out flames, cleaning up toxic foams in seas and rivers, or simply getting the perfect rise on a cake, getting to grips with how foam materials collapse is vital to tailoring their properties, ...
2021-02-27
Korea Brain Research Institute (KBRI, President Suh Pann-ghill) announced that the research team led by Dr. Jae-Yeol Joo discovered new cryptic splice variants and SNVs in PLCg1 gene of AD-specific models for the first time using Splice-AI.
This research outcome was published in PNAS, a world-renowned academic journal.
* (Title) Prediction of Alzheimer's Disease-Specific phospholipase c gamma-1 SNV by Deep Learning-Based Approach for High-Throughput Screening
Alternative splicing variant regulates gene expression and influences diverse phenotypes. Especially, genetic ...
2021-02-26
Marine protected areas (MPAs) around O?ahu do not adequately protect populations of herbivorous reef fishes that eat algae on coral reefs. That is the primary conclusion of a study published in Coral Reefs by researchers from the University of Hawai?i at Mānoa School of Ocean and Earth Science and Technology (SOEST).
There are over 20 species of herbivorous fishes and ten species of herbivorous urchins commonly observed on Hawaiian reefs. These species eat algae that grows on reefs, a process called herbivory, that contributes to the resilience of coral reefs by preventing algae dominance that can lead to overgrowth of corals.
The team of researchers found that of the four marine protected areas around O?ahu they assessed in the study, ...
2021-02-26
The ability to read is foundational to education, but prolonged school closures and distance learning due to the pandemic have imposed unique challenges on the teaching of many fundamental skills. When in-person classes resume, many students will likely need a period of catch-up learning, especially those who lag behind in basic reading skills.
New research published in the journal Psychological Science shows that people who were taught to read by receiving explicit instructions on the relationship between sounds and spelling experienced a dramatic improvement compared to learners who discovered this relationship naturally through the reading process. These results contribute to an ongoing debate about how best to teach children to ...
2021-02-26
New research from Baylor College of Medicine scientists shows that a combination of deep brain stimulation (DBS) and exercise has potential benefits for treating ataxia, a rare genetic neurodegenerative disease characterized by progressive irreversible problems with movement.
Working with a mouse model of the human condition, researchers at Baylor and the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital discovered that combining DBS targeted to the cerebellum, a major motor center in the brain, and exercise rescued limb coordination and stepping and that the benefits persisted without further stimulation. In addition, the study reports that stimulating mice with early-stage ataxia showed the most dramatic improvements. These and other ...
2021-02-26
BOSTON -- Billions of peripheral white blood cells are produced every day by the regular divisions of hematopoietic stem cells and their descendants in the bone marrow. Under normal circumstances, thousands of stem cells contribute progeny to the blood at any given time, making white blood cells a group with diverse ancestry.
Clonal hematopoiesis is a common age-related condition in which the descendants of one of these hematopoietic stem cells begin to dominate substantial portions of the blood. Genome-wide analyses have determined that clonal ...
LAST 30 PRESS RELEASES:
[Press-News.org] Financial incentives for hospitals boost rapid changes to opioid use disorder treatment
Offering financial incentives to hospitals shows strong potential to drive swift system and practice changes to intervene in the opioid epidemic, Penn Medicine research finds
